Correlation Between Regeneron Pharmaceuticals and Small Cap

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Small Cap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Small Cap into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Small Cap Premium, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Small Cap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Small Cap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Small Cap.

Diversification Opportunities for Regeneron Pharmaceuticals and Small Cap

-0.77

Correlation Coefficient

Regeneron Pharmaceuticals  Small Cap

Pay attention - limited upside

The 3 months correlation between Regeneron and Small is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Small Cap Premium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Small Cap Premium and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Small Cap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Small Cap Premium has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Small Cap go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Small Cap

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Small Cap. In addition to that, Regeneron Pharmaceuticals is 3.2 times more volatile than Small Cap Premium. It trades about -0.35 of its total potential returns per unit of risk. Small Cap Premium is currently generating about 0.06 per unit of volatility. If you would invest  2,399  in Small Cap Premium on September 29, 2024 and sell it today you would earn a total of  46.00  from holding Small Cap Premium or generate 1.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Small Cap Premium

Regeneron Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Small Cap Premium

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Small Cap Premium are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Small Cap is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Regeneron Pharmaceuticals and Small Cap

The main advantage of trading using opposite Regeneron Pharmaceuticals and Small Cap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Small Cap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Small Cap will offset losses from the drop in Small Cap's long position.

The idea behind Regeneron Pharmaceuticals and Small Cap Premium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.